“…Heterocyclic compounds containing 3-(2H)-pyridazinone moiety in their structures have attracted a great deal of attention due to their wide spectrum of biological activity such as antimicrobial (Sayed et al, 2002;Katrusiak & Baloniak, 1994), antiinflammatory (Dogruer et al, 2003;Pieretti et al, 2006), antifeedant (Cao et al, 2003), herbicidal (Piaz et al, 1994;Xu et al, 2008), antiplatelet Coelho et al, 2007), anticancer (Malinka et al, 2003), antihypertensive (Wexler et al, 1996;Barbaro et al, 2001), antinociceptive agent Vergelli et al, 2007) and other biological and pharmacological properties (Abudshait, 2007). In our study toward the synthesis of dihydropyridazinones as potential candidates for antihypertensive activity the structure of methyl 4-[6-(4-bromophenyl)-3-oxo-2,3,4,5-dihydropyridazin-4-ylmethyl]benzoate has been determined.…”